The close association between the P2X7 receptor and inflammation and the fact that IBS patients display both mucosal and neural inflammation motivate us to assume that, by inhibiting the P2X7 receptor, comorbid chronic visceral pain and depression could be alleviated. Here, P2RX7 is linked to depressive symptom measurement.